Waldencast plc

Contributing Author

Recent Articles by Waldencast plc

Jul-30	Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint WALD +5.23% GlobeNewswire
Jun-15	Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel WALD GlobeNewswire
Jun-01	Waldencast Announces Sale of Obagi Medical to Bridgepoint WALD +48.78% GlobeNewswire
May-15	Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting WALD -9.82% GlobeNewswire
May-14	Obagi and Next Health Partner to Launch "The Skin Recharge Station" Pop-Up Experience WALD GlobeNewswire
Apr-30	Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin* WALD +16.64% GlobeNewswire
Apr-28	Waldencast announces conclusion of SEC investigation WALD GlobeNewswire
Mar-24	Obagi Medical Introduces NU-GEN Cellular Renewal Serum Designed to Visibly Rewind Skin's Age and Restore Visible Youthfulness WALD -7.38% GlobeNewswire
Mar-19	Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi saypha MagIQ WALD -8.28% GlobeNewswire
Mar-13	Waldencast Reports Q4 2025 and FY 2025 Financial Results WALD +8.22% GlobeNewswire
Mar-11	Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date WALD GlobeNewswire
Feb-27	Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD GlobeNewswire
Feb-25	Obagi Medical and It's a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD GlobeNewswire
Feb-17	Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD GlobeNewswire
Feb-06	Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD GlobeNewswire
Feb-05	Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD GlobeNewswire
Feb-03	Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect WALD +5.26% GlobeNewswire
Jan-30	Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD +13.48% GlobeNewswire
Jan-28	Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD -5.69% GlobeNewswire
Jan-27	UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi saypha MagIQ WALD GlobeNewswire
Jan-27	Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi saypha MagIQ WALD GlobeNewswire
Jan-26	CORRECTION - Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD GlobeNewswire
Jan-26	Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi saypha MagIQ WALD GlobeNewswire
Jan-21	Obagi Medical Unveils ALOHA Program to Launch Obagi saypha MagIQ - Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler WALD +6.92% GlobeNewswire
Nov-24	Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update WALD -6.49% GlobeNewswire
Nov-16	Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting WALD GlobeNewswire
Nov-14	Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities WALD GlobeNewswire
Nov-12	Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates WALD GlobeNewswire
Oct-08	Obagi Medical Launches Nu-Cil BioStim Scalp Serum WALD +7.58% GlobeNewswire
Sep-10	Waldencast Announces FDA Approval of Obagi saypha MagIQ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand WALD -9.19% GlobeNewswire
Aug-18	Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation WALD GlobeNewswire
Jul-23	Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha, Under the Obagi Medical Brand WALD GlobeNewswire
May-13	Waldencast Reports Q1 2025 Financial Results WALD WALD -20.79% GlobeNewswire
May-06	Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast WALD GlobeNewswire

Waldencast plc

Recent Articles by Waldencast plc

Upgrade your Finviz experience